250 results on '"Warnecke, G"'
Search Results
2. (908) Does Donor-Recipient Sex Mismatch Have an Influence on Long Term Outcomes after Lung Transplantation? An Experience of a High Volume Center
3. (1264) Recipients of Extended Criteria Ex Situ Preserved Lungs Display Higher Plasma Levels of Cytokines and Endothelial Markers after Lung Transplantation Without Higher PGD Scores
4. (410) Perioperative Desensitization Changes the Plasma Cytokine Milieu in Lung Transplant Patients with Preformed Donor Specific Antibodies
5. 12-Year Experience with Postoperatively Extended Intraoperative Extracorporeal Membrane Oxygenation in Lung Transplantation for Patients with Severe Pulmonary Arterial Hypertension
6. (101) Nine-Year Experience with Treatment of Early Detectable Donor Specific Anti-HLA Antibodies in Pediatric Lung Transplant Recipients
7. (921) Effect of Surgical Exposure on Short-Term Outcomes after Bilateral Lung Transplantation
8. (120) Heart Preservation with the Organ Care System in Extended Criteria Donor Hearts: A Single Center Experience
9. Eight-Year Results of an IgA- and IgM-Enriched Human Immunoglobulin-Based Therapy for Early Detectable Anti-HLA Donor Specific Antibodies After Lung Transplantation
10. Full Recovery of Right Ventricular Systolic Function in Children Undergoing Bilateral Lung Transplantation for Severe PAH
11. Long-Term Results of the OCS Lung Expand International Trial Using Organ Care System Lung Perfusion System (OCS) in Extended-Criteria Donor (ECD) and Donation After Circulatory Death (DCD) Donor Lungs
12. Risk Factors for the Development of Early Anti-HLA Donor Specific Antibodies After Lung Transplantation: The Role of Primary Graft Dysfunction
13. Lung Transplant Recipients Developing Early DSAs within the First Month Are Characterized by a Higher Frequency of Naïve and a Lower Frequency of Memory B Cells
14. Influence of Tricuspid Regurgitation After Heart Transplantation: A 10-Year Single Center Experience
15. Results of Temporary Right Heart Assist Device Implantation Following Right Heart Failure
16. Primary Graft Dysfunction Following Lung Transplantation is Associated with Increased In Vivo T Cell Alloreactivity: Evidence from a Humanized Mouse Model
17. Using Donor Lungs ≥70 Years of Age for Transplantation - Do Long-Term Outcomes Justify the Use?
18. Perioperative Desensitization with IgA- and IgM-Enriched Human Immunoglobulins Allows Safe Lung Transplantation in Patients with Preformed Donor Specific Antibodies
19. How to Heal a Broken Heart with Time and a Hybrid Mechanical Circulatory Support Armada
20. Liver-First Strategy for Combined Lung and Liver Transplantation: 15-Year Single-Center Experience
21. Donor T and NK Cells with a Special Tissue-Resident Memory Phenotype Migrate into the Periphery of Lung Transplant Recipients - A Potential Feature for Tolerance Development
22. Adverse Events in HVAD vs. HM3 Patients under Outpatient Bridging with Low-Molecular Weight Heparin for Subtherapeutic Anticoagulation
23. Lung Transplantation and Concomitant Coronary Artery Bypass Grafting Does Not Impair Patient Outcomes: Insights from a Single-Center Experience
24. Seven-Year Clinical Results of an IgA-and IgM-Enriched Human Immunoglobulin-Based Therapy for Antibody-Mediated Rejection after Lung Transplantation
25. Impact of Cold Ischemic Time on Morbidity and Mortality after Lung Transplantation. An Updated Analysis of the International Multicenter Extracorporeal Life Support in Lung Transplantation Registry
26. A Transplanted Broken Heart Healed with Time and Temporary Mechanical Circulatory Support
27. Heart-Associated Cytokine and Endothelial Patterns Dominate the Ischemia/Reperfusion Response in Recipients of Combined Heart/Lung Transplantation in Comparison to Lung Transplantation
28. Treatment of Anti-HLA Donor-Specific Antibodies in Heart Transplantation: A Single-Center Experience
29. Effect of Surgical Exposure on Outcomes in Lung Transplantation: Insight from the International Multicenter Extracorporeal Life Support (ECLS) in Lung Transplantation Registry
30. Ex Situ Heart Perfusion and Standard of Care Cold Storage Differentially Affect the Ischemic Secretome of Donor Hearts in Perfusates but Not the Reperfusion Response in Recipient Plasma
31. Fifteen-Year Single Center Experience with Lung Transplantation in Pediatric Patients Younger Than 12 Years Old
32. Donor T and NK Cells with a Special Tissue-Resident Memory Phenotype Migrate into the Periphery of Lung Transplant Recipients - A Potential Feature for Tolerance Development
33. Regulatory T Cells and the Effect of Ex Vivo Preservation on the Development of Transplant Arteriosclerosis in a Humanized Mouse Model
34. Influence of Donor-Recipient Age Mismatch in Young Lung Transplant Recipients
35. Preformed Donor Specific Antibodies in Lung Transplantation - Perioperative Desensitization Using IgA- and IgM-Enriched Immunoglobulins
36. 10-Year Experience with Postoperatively-Extended Intraoperative Extracorporeal Membrane Oxygenation in Lung Transplantation for Patients with Severe Pulmonary Hypertension
37. The Ratio between Naïve and Memory B Cells is Associated with Development of Early Donor-Specific Antibodies within the First Month after Lung Transplantation
38. Extracorporeal Life Support Registry: Analysis of Ex Vivo Lung Perfusion Utilization in Donor after Cardiac Death and Donor after Brain Death
39. Interim Results - The Effect of Donor Type (Donor after Cardiac Death vs Donor after Brain Death) and Use of Intraoperative Extracorporeal Lung Support on Survival after Lung Transplantation
40. From Heart Failure via Biventricular Assist Device to Heart Transplantation
41. Impact of Donor Quality on Recipient Outcomes in Lung Transplantation: 10-year Single-Center Experience Using the Eurotransplant Lung Donor Score
42. ePS3.04 NCR+ Type 3 Innate lymphoid cells are increased in lung tissue, bronchial lymph nodes and peripheral blood of cystic fibrosis patients
43. Correlation of CLAD in Lung Transplant Recipients with Transplant Arteriosclerosis in Humanized Mice: A 5-years Follow Up Analysis
44. Impact of Diaphragmatic Dysfunction on Postoperative Course after Bilateral Lung Transplantation
45. In Combined Heart/Lung Transplantation, the Reperfusion Response in Recipients is Dominated by Heart-Associated Cytokine and Endothelial Patterns While the Ischemic Injury in the Storage Solution is Dominated by a Lung-Associated Microenvironment
46. Donor T and NK Cells with a Special Tissue-Resident Memory Phenotype Migrate into the Periphery of Lung Transplant Recipients - A Potential Feature for Tolerance Development
47. Treatment of Anti-HLA Donor-Specific Antibodies in Heart Transplantation: A Single-Center Experience
48. Ex Vivo Organ Perfusion for Heart Procurement in High-Risk Transplantations: A Multicenter Study
49. Normothermic Ex-Vivo Perfusion for Donor Heart Preservation in Transplantation of Patients Bridged with Ventricular Assist Devices
50. Heart Preservation with the Organ Care System in Extended Criteria Donor Hearts: A Three-Center Experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.